9 July 2020

URV Activ@ - Diari digital de la Universitat Rovira i Virgili ·

Advanced search

Show all news from "Health"

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”

A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard University with collaborators from the Broad Institute and Universitat Rovira i Virgili